Atezolizumab
泰圣奇(Tecentriq)
A PD-L1 checkpoint inhibitor immunotherapy (Roche).
At a glance
China price
Verified pricing is not currently available.
NRDL (national insurance)
In NRDL for selected indications.
Regulatory status
NMPA approved; NRDL /
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
SourceNo independent source on file.
NotesApproval status from public regulatory reporting.
What it treats
Small-cell and non-small-cell lung cancer, liver cancer per Chinese label.
(himd.com)
Sources & verification
No independent source is currently on file. We have not independently verified this information.
Reader discussion
Public comments about Atezolizumab. Discussion is not medical advice, and a comment is not an endorsement or a verified fact. Open the full forum.